Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$384.66
-123.80-24.35%
Last update: Apr 23, 10:06 AM
Medpace Holdings Inc Analyst Ratings
MEDPNASDAQ
Earnings: Q1 2026 Earnings were released on Wed Apr 22nd, after the market close
Medpace Holdings Analyst Ratings and Price Targets | NASDAQ:MEDP | Benzinga
Medpace Holdings Inc has a consensus price target of $486.33 based on the ratings of 16 analysts. The high is $655 issued by Mizuho on October 24, 2025. The low is $305 issued by UBS on July 29, 2025. The 3 most-recent analyst ratings were released by Barclays, RBC Capital, and TD Cowen on March 6, 2026, March 3, 2026, and February 18, 2026, respectively. With an average price target of $480.33 between Barclays, RBC Capital, and TD Cowen, there's an implied 24.44% upside for Medpace Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
RBC Capital
TD Cowen
Jefferies
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Medpace Holdings
Loading calendar...
FAQ
What is the target price for Medpace Holdings (MEDP) stock?
The latest price target for Medpace Holdings (NASDAQ:MEDP) was reported by Barclays on March 6, 2026. The analyst firm set a price target for $500.00 expecting MEDP to rise to within 12 months (a possible 29.98% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medpace Holdings (MEDP)?
The latest analyst rating for Medpace Holdings (NASDAQ:MEDP) was provided by Barclays, and Medpace Holdings upgraded their equal-weight rating.
When was the last upgrade for Medpace Holdings (MEDP)?
The last upgrade for Medpace Holdings Inc happened on March 6, 2026 when Barclays raised their price target to $500. Barclays previously had an underweight for Medpace Holdings Inc.
When was the last downgrade for Medpace Holdings (MEDP)?
The last downgrade for Medpace Holdings Inc happened on October 2, 2025 when Barclays changed their price target from $450 to $425 for Medpace Holdings Inc.
When is the next analyst rating going to be posted or updated for Medpace Holdings (MEDP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medpace Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medpace Holdings was filed on March 6, 2026 so you should expect the next rating to be made available sometime around March 6, 2027.
Is the Analyst Rating Medpace Holdings (MEDP) correct?
While ratings are subjective and will change, the latest Medpace Holdings (MEDP) rating was a upgraded with a price target of $500.00 to $500.00. The current price Medpace Holdings (MEDP) is trading at is $384.66, which is out of the analyst’s predicted range.
